Get startedLog in
    Picture of Theravance Biopharma logo

    TBPH — Theravance Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedMid CapHigh Flyer
    All News

    Brief: Theravance Biopharma- On Dec 26 Units, Mylan Ireland & Mylan Specialty L.P. Entered Settlement Agreement With Accord Healthcare

    Picture of Theravance Biopharma logoTheravance Biopharma
    28/12/2023 11:18
    Dec 28 (Reuters) - Theravance Biopharma Inc  TBPH.O :
    * ON DEC 26 UNITS, MYLAN IRELAND & MYLAN SPECIALTY L.P.
ENTERED
SETTLEMENT AGREEMENT WITH ACCORD HEALTHCARE
    * SETTLEMENT AGREEMENT WITH ACCORD HEALTHCARE RELATING TO
THERAVANCE AND MYLAN'S YUPELRI (REVEFENACIN) INHALATION SOLUTION
    * UNDER DEAL, ACCORD GRANTED LICENSE TO MANUFACTURE, MARKET
ACCORD'S GENERIC VERSION OF YUPELRI IN U.S ON/ AFTER APRIL 23,
2039

Source text for Eikon:  ID: 
Further company coverage:  TBPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Theravance Biopharma

    See all news